Abstract
In order to assess the feasibility of using a type and screen procedure in Kyoto, our laboratory did a retrospective study of 31, 490 crossmatches performed on 4, 276 patient samples. This included analysis of 672 patients who had positive antibody histories, and the distribution of the antibody specificities they developed. This study also reviewed a single (0.03%) case in which a patient with no history of antibody problems, and negative antibody screening, had an incompatible crossmatch. We also reviewed 11 (2.42%) cases of patients with histories of positive antibody screenings in which the current sample was nonreactive but the crossmatch was incompatible.We have concluded that patient safety would not be at risk if certain essential guidelines are met when adopting a type and screen procedure.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
